Tissu has emerged as the brand leader in stem cell treatments. This dynamic young company was founded in the United Kingdom by a dedicated team of Western trained doctors, scientists and clinicians, whose sole objective was to be the best in this revolutionary field of medicine.
This has been achieved by providing patients with the very best of regenerative and rejuvenating treatments that modern medicine and science has to offer.
It is also the only company in the world that is permitted by a national Government (The Seychelles) to provide stem cell treatment under license and with bone fide legal authority. These treatments are in strict accordance with the Seychelles Department of Health guidelines.
We are the only stem cell treatment institution that publishes all its results and we will not provide biased and unsubstantiated results. Every patient treated by our clinics is followed up for life, as we aim to publish ground breaking data. Our scientific team have already created many of the benchmarks for stem cell treatment and many other clinics already aspire to follow our mission statement in providing the best of the best for the best results.
Our partnership with some of the most reputable universities in the world, medical institutes, researchers, facilities and the Seychelles Government provides patients with cost-effective stem cell treatment in the Seychelles, where the prescribed therapy is compliant and approved by local health regulations. Since we are a government affliated institution we are duty bound to only provide stem cell treatment in an ethical, sensitive and legally approved framework.
We aim to empower patients and educate them about this new breakthrough in medicine, so that treatment for patients with stem cells is a reality and not just only a fanciful dream for the chronically sick, who may not be able to afford to go to expensive backstreet clinics in underdeveloped parts of the world.
Stem cell based technology offers amazing possibilities for the future. These include the ability to reproduce human tissues and potentially repair damaged organs. For many diseases modern medical science has no cures and at best provides supportive care.
The potential curative power of stem cells “almost silences” the sternest critics of such technology, but the fact remains there are great ethical challenges for our society to overcome. These range from the ethics of ownership of umbilical cord stem cells to the currently unregulated treatments that operate in many countries.
The notion of right and wrong in this area is contentious. Our society stands to grow and change in the process of tackling these challenges. Withholding potentially life-saving and curative treatments because of the interests of vocal interest groups would be unfair. Medicine has always dealt with the fine balancing act between risk and benefit by a process of open discussion at the doctor – patient level.
It is encouraging that, in tackling these challenges, we stand to reflect a great deal about the ethics of our profession and our relationships with patients, industry, and each other.
Pandya SK. Stem cell transplantation in India: tall claims, questionable ethics. Indian J Med Ethics. 2008 Jan-Mar;5(1):15-7.
Rosenfeld JV, Gillett GR Ethics, stem cells and spinal cord repair MJA 2004; 180 (12): 637-639
Peter Lachmann. Stem cell research—why is it regarded as a threat?
An investigation of the economic and ethical arguments made against research with human embryonic stem cells
Peter Lachmann is President of the Academy of Medical Sciences in London European Molecular Biology Organization (EMBO)EMBO reports 2, 3, 165–168 (2001)doi:10.1093/embo-reports/kve053
